QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAIn-House SPPS1-Region Domestic Shipping
What is BPC-157 + TB-500 Blend?
BPC-157 + TB-500 Blend combines two complementary recovery peptides in oral tablet form: BPC-157 (pentadecapeptide gut-protective/tissue repair agent) and TB-500 Fragment (actin-binding Thymosin Beta-4 active domain). BPC-157 supports gut mucosal healing, angiogenesis, and systemic tissue repair via growth factor signalling; TB-500 drives actin polymerisation, cell migration, and anti-inflammatory cytokine modulation. Oral formulation for GI absorption pathway studies. Research use only.
Research Applications
Oral Peptide GI Absorption
BPC-157 + TB-500 oral bioavailability, gastric stability, intestinal uptake
Synergistic Tissue Repair
Combined BPC-157 + TB-500 wound healing — additive vs synergistic effect
Gut Mucosal Healing
BPC-157 intestinal mucosa repair, epithelial barrier restoration, IBD models
Anti-Inflammatory Dual Pathway
BPC-157 VEGFR2 + TB-500 actin/cytokine — complementary NF-κB modulation
Musculoskeletal Recovery
Tendon, ligament, muscle fibre repair — combined growth factor and actin pathways
Quick Specs
| Form | Tablet — 1000mcg blend per tablet, 100-tablet bottle |
| CAS Number | 137525-51-0 / 107761-42-2 |
| Molecular Formula | BPC-157 C₆₂H₉₈N₁₆O₂₂ + TB-500 Fragment C₂₁H₃₈N₈O₇S |
| Molecular Weight | 1419.5 / 562.6 g/mol |
| Compound Type | Dual Recovery Peptide Blend (BPC-157 + TB-500) |
| Purity | ≥99% by HPLC — every batch |
| Identity | MS molecular weight confirmed — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Manufacture | In-house synthesis — Qingdao, China |
| Storage | Room temperature sealed | cool, dry storage | protect from moisture |
| Shelf Life | 24 months unopened |
